Pharmaceutical Liability
The Opioid Crisis by The Numbers
Opioid Liability for Injury and Death
The opioid industry is facing unprecedented backlash from private citizens and government officials as more individuals fall victim to addiction, injury and even death related…
Read MoreJury Awards $27.8 Million in Damages to Patient Injured by Xarelto®
On December 5, 2017, a Philadelphia jury ordered Bayer AG and Johnson & Johnson to pay over $27 million in damages to a patient injured…
Read MoreFDA: Clinical Trials Show Increased Risk of Amputation with Invokana
Recent safety communications published by the US Food and Drug Administration indicate that type 2 diabetes drug, Invokana (canagliflozin), can cause increased risk for foot…
Read MoreWhat Patients Need to Know About Actos
The pharmaceutical liability attorneys at The Law Offices of Peter Angelos discuss the dangers of Actos—a common Type 2 Diabetes medication. Actos, a common Type…
Read MoreXarelto®: A Year in Review
In November, 2015, the U.S. District Court for the Eastern District of Louisiana announced that the first of the Xarelto® bellwether trials, stemming from the…
Read MorePPI Lawsuits: What’s Next?
The pharmaceutical liability attorneys at The Law Offices of Peter Angelos provide information regarding the risks related to proton pump inhibitors and the lawsuits filed…
Read MoreFamilies Claim that Manufacturer Should Have Warned of Zofran Risks
The FDA approved Zofran, an antiemetic medication manufactured by GlaxoSmithKline (GSK) to prevent nausea and vomiting caused by cancer chemo therapy, radiation therapy, and surgery.…
Read MoreNew Risk Associated with PPI Drugs
Proton pump inhibitors (PPIs) are a class of medication used to treat a number of common abdominal conditions such as gastroesophageal reflux disease, stomach and…
Read MoreBlood Thinner Safety: What to Know When Taking Xarelto
Blood clots have the ability to prevent blood flow to patients’ organs such as the heart, lungs, and kidneys, potentially causing stroke and other life-threatening…
Read More